MENEVERI RAFFAELLA

Villa, M., Malighetti, F., Sala, E., Sharma, G., Arosio, G., Gemelli, M., et al. (2024). New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ PRECISION ONCOLOGY, 8(1) [10.1038/s41698-024-00498-w]. Detail

Barone, C., Orsenigo, R., Cazzola, A., D'Errico, E., Patelli, A., Quattrini, G., et al. (2023). Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation. CANCERS, 15(14) [10.3390/cancers15143624]. Detail

Vitulo, M., Gnodi, E., Rosini, G., Meneveri, R., Giovannoni, R., Barisani, D. (2023). Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(16) [10.3390/ijms241612748]. Detail

Villa, M., Malighetti, F., Sharma, G., Arosio, G., Sala, E., Manfroni, C., et al. (2022). Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy. Intervento presentato a: 62nd SIC Annual Meeting. The exciting path from preclinical research to clinical application, Venezia, Italia. Detail

Vitulo, M., Gnodi, E., Meneveri, R., Barisani, D. (2022). Interactions between Nanoparticles and Intestine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(8) [10.3390/ijms23084339]. Detail